Anzeige
Mehr »
Login
Mittwoch, 02.10.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldshore legt um 425 % zu: Diese winzige Goldaktie übertrifft Barrick um 400 %!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
413 Leser
Artikel bewerten:
(2)

Immunoassay Market Size to Reach USD 55.85 Billion in 2030 | Emergen Research

VANCOUVER, B.C., Jan. 19, 2023 /PRNewswire/ -- The Immunoassay Market size reached USD 39.72 Billion in 2021 and is expected to register a CAGR of 3.9% during the forecast period, according to latest analysis by Emergen Research. Increase in prevalence of chronic diseases, and introduction of technically advanced systems and technologies are some key factors driving dental equipment market revenue growth.

Emergen_Research_Logo

According to the National Diabetes Statistics Report, about 37.3 million individuals in the United States developed diabetes by 2020, with over 96 million adults having pre-diabetes. Furthermore, increased R&D spending by government organizations and pharmaceutical corporations for disorders and diseases such as chronic ailments and diabetes is boosting the global market. According to Pharmaceutical Research and Manufacturers of America, the biopharmaceutical sector would invest an estimated USD 102.3 billion in R&D in 2021.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1507

Drivers:

Technological advancements in immunoassay techniques are leading to an increase in global demand for immunoassay techniques. Recent product introductions by leading industry competitors are also contributing to market growth. For instance, on May 2022, Abbott announced the launch of the HBsAg Next Qualitative solution in India to improve Hepatitis B viral diagnosis (HBV). This test will aid in the improvement of patient outcomes while ensuring the safety of blood supplies. This extremely sensitive chemiluminescent microparticle immunoassay (CMIA) aids in the detection of HBV in human serum and plasma (blood) samples, as well as population screening. A chemiluminescent immunoassay is a biochemical method used in immunology that differs from the usual enzyme immunoassay. Furthermore, on April 2020, the ErbaLisa COVID-19 ELISA kits for the detection of IgG and IgM antibodies to SARS-CoV-2 have been developed by Erba Mannheim. The tests may be run manually or with any open automated ELISA analyzer, like the Erba Mannheim ELAN 30s.

Restraints:

There are some issues and difficulties facing the immunoassay market. One of the significant factors hindering the growth of the market is specificity and false positive results. The presence of other substances in the sample can interfere with the assay, leading to false positive results. Non-specific binding of the antibodies may bind to substances other than the target analyte and can give inaccurate results. The sensitivity of the technique is also a major issue. The assay may not be sensitive enough to detect low levels of the target analyte.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1507

Growth Projections:

The Immunoassay Market is expected to register a CAGR of 3.9% over the forecast period and revenue is projected to increase from USD 39.72 Billion in 2021 to USD 55.85 Billion in 2030. Research and development of immunoassay technique are expected to support revenue growth of the market.

Current Trends and Innovations:

The Immunoassay market is undergoing gradual changes during the forecast period. Immunoassays are laboratory tests that use the principle of antigen-antibody interactions to detect and quantify specific substances in a sample. Over the years, immunoassays have undergone significant developments, and some current trends in the field include Point-of-care (POC) testing, multiplexed assays, microfluidics-based assays, biosensors, Artificial intelligence (AI), and Machine Learning (ML). For instance, multiplexed assays allow for the simultaneous detection of multiple analytes in a single sample, which can increase the efficiency of testing and reduce costs. In addition, microfluidic-based immunoassays are becoming more popular in POC testing and in the field of personalized medicine.

Strategic Initiatives:

Major companies included in the market report are Siemens Healthcare GmbH, Biomérieux, Abbott, Becton Dickinson and Company, Beckman Coulter, Inc., Hologic, Inc., Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific.

  • On November 2021, at MEDICA 2021, Boditech Med introduced its new automated immunoassay analyzer, AFIAS-10, which features a blood collection tube and all-in-one cartridge system. The AFIAS-10 is a one-of-a-kind, integrated Sample-to-Answer system that can simultaneously perform 10 different tests for various parameters.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/immunoassay-market

Scope of Research

Report Details

Outcome

Market Size in 2021

USD 39.72 Billion

CAGR (2022-2030)

3.9 %

Revenue Forecast to 2030

USD 55.85 Billion

Base Year for Estimation

2021

Historical Data

2019-2020

Forecast Period

2022-2030

Quantitative Units

Revenue in USD Billion and CAGR in % from 2022 to 2030

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

product, technology, application, end-use, and region

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country Scope

U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa

Key Companies Profiled

Siemens Healthcare GmbH, Biomérieux, Abbott, Becton Dickinson and Company, Beckman Coulter, Inc., Hologic, Inc., Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific

Customization Scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1507

Emergen Research has segmented Immunoassay on the basis of product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2019-2030)
    • Reagents and kits
    • Instruments
  • Technology Type Cycle Outlook (Revenue, USD Billion; 2019-2030)
    • Radioimmunoassay (RIA)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Rapid Test
    • Fluoroimmunoassay (FIA)
    • Chemiluminescence immunoassay (CLIA)
    • Others
  • Application Outlook (Revenue, USD Billion; 2019-2030)
    • Therapeutic Drug Monitoring
    • Oncology
    • Cardiology
    • Endocrinology
    • Infectious Disease Testing
    • Autoimmune Diseases
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2019-2030)
    • Hospitals
    • Biotechnology & Pharmaceutical Industries
    • Blood Banks
    • Clinical Laboratories
    • Academic Research Centers
    • Others
  • Regional Outlook (Revenue, USD Billion, 2019-2030)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Benelux
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of APAC
    • Latin America
      • Brazil
      • Rest of LATAM
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Turkey
      • Rest of MEA

Latest Research Reports Published by Emergen Research:

Gas Treatment Market, By Type (Amines and Non-Amines), By Application (Dehydration and Acid Gas Removal), and By Region Forecast to 2030

Flight Simulator Market, By Method (Synthetic and Virtual), By Type (Flight Training Devices, Full Flight Simulators, Full Mission Flight Simulators, and Fixed Base Simulators), By Platform (Commercial and Military), and By Region Forecast to 2030

Electronic Flight Instrument System Market, By Platform (Commercial Aviation, Military Aviation, and General Aviation), By Application By Fit (Line-Fit and Retrofit), and By Region Forecast to 2030

Space Cryogenics Market By Cooling Type (High Temperature and Low Temperature Coolers), By Component Type (Low Conductive Supports, Multilayer Insulation, V-Groove Shields), By Application and By Region Forecast to 2030

Smart Shelves Market By Component (Hardware, Software & Solutions, and Professional Services), By Organization Size (Large Enterprises and Small & Medium-Sized Enterprises), By Application, and By Region Forecast to 2030

Connected Toys Market, By Application (Education and Entertainment), By Age Group (1-5 Years, 6-8 Years, 9-12 Years, and Teenagers (13-19 Years)), By Distribution Channel (Online and Offline), and By Region Forecast to 2030

Negative Pressure Wound Therapy Market, By Product Type (Conventional NPWT, Single-Use NPWT, and Accessories), By Wound Type, By End-Use, and By Region Forecast to 2030

Hypercholesterolemia Market, By Disease Type (Genetic and Acquired), By Treatment Type (Statins, Bile-acid Binding Resins, Niacin, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-immunoassay-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/immunoassay-market-size-to-reach-usd-55-85-billion-in-2030--emergen-research-301725738.html

© 2023 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.